ADELA
Adela develops innovative and accessible technologies focusing on the detection of cancer and other high-morbidity, high-mortality conditions through a routine blood test. Adela’s genome-wide methylome enrichment platform captures information efficiently from the entire methylome. Its technology distinguishes the most-highly informative (methylated) regions of the genome from non-informative regions and preferentially targets those regions for sequencing.
ADELA
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2020-01-01
Address:
Foster City, California, United States
Country:
United States
Website Url:
http://www.adelabio.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
108 M USD
Technology used in webpage:
U.S. Server Location
Similar Organizations
Base Molecular Resonance Technologies
Base Molecular Resonance Technologies detects every element on the periodic table and detects cancer.
Intellihealth
Intellihealth is changing the perception of obesity and redefining how it is treated.
Next Medical
Next Medical is a developer and operator of a patient-centric telemedicine platform intended to fast-track medical testing.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Sapphiros
Sapphiros invest in and provide operational support to a select cohort of innovative diagnostics companies.
Thrive Earlier Detection
Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.
Trice Medical
Trice Medical specializes in providing solutions for orthopedic diagnostics.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
F-Prime Capital
F-Prime Capital investment in Series A - Adela
LabCorp
LabCorp investment in Series A - Adela
OrbiMed
OrbiMed investment in Series A - Adela
Decheng Capital
Decheng Capital investment in Series A - Adela
RA Capital Management
RA Capital Management investment in Series A - Adela
Deerfield Management
Deerfield Management investment in Series A - Adela
Deerfield
Deerfield investment in Series A - Adela
RA Capital Management
RA Capital Management investment in Series A - Adela
F-Prime Capital
F-Prime Capital investment in Series A - Adela
OrbiMed
OrbiMed investment in Series A - Adela
Key Employee Changes
| Date | New article |
|---|---|
| 2023-12-14 | Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO |
Official Site Inspections
http://www.adelabio.com Semrush global rank: 9.02 M Semrush visits lastest month: 445
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Adela"
ADELA | A breakthrough approach to early detection - adelabio.com
Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can …See details»
Story Adela - uhncommercialization.ca
Adela advances precision medicine Developing next-generation cancer detection in a single blood draw Today, cancer and other diseases are often caught too late for treatments to be effective. …See details»
Adela 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Adela. Use the PitchBook Platform to explore the full profile.See details»
Toronto biotech startup Adela raises $60-million from top U.S ...
Jun 23, 2021 A leading biotechnology startup from Toronto's University Health Network (UHN) has raised US$60-million form some of the biggest U.S. investors in the sector to help develop …See details»
Adela - Crunchbase Company Profile & Funding
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.See details»
Adela Company Profile - Office Locations, Competitors, Revenue
Adela $60 m in total funding,. See insights on Adela including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Adela - VentureRadar
"Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test. The DNA methylome is a rich source of information about human …See details»
Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO
Serving most recently as interim CEO to Adela, she has already demonstrated her ability to engage and lead this mission-driven organization in delivering results.”See details»
Adela (USA) Funding: $108M
Jul 7, 2025 USA | Funding: $108M (+) Website: https://www.adelabio.com Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.See details»
Adela Announces Executive and Board of Directors Appointments …
May 23, 2022 "Her experience will be invaluable to Adela as we advance the organization towards commercialization." Lisa is the co-founder and CEO of Genome Medical, the leading …See details»
Adela - Portfolio Company Profile, Executives and Private Equity …
See Adela's complete profile, including its private equity owner and the number of its executive contacts in our database. Adela is a biotechnology company focused on the detection of …See details»
Biotech startup Adela procures $60m in Series A financing
Jun 23, 2021 Toronto-based biotechnology startup Adela has launched with a $60 million Series A financing. F-Prime led the round, with participation from OrbiMed, Deerfield Management, …See details»
Adela Announces Executive and Board of Directors Appointments …
May 23, 2022 Adela, Inc., focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test, has made appointments to the Executive Team and …See details»
Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO
Dec 15, 2023 FOSTER CITY - Adela, Inc., an innovator in blood testing for minimal residual disease monitoring and early cancer detection through a proprietary genome-wide methylome …See details»
ADELA | Adela’s Co-Founder & Chief Scientific Officer, Dr. Daniel …
The Canada Gairdner Awards celebrate the world’s best biomedical and global health researchers FOSTER CITY, Calif., April 11, 2025 /PRNewswire/ -- Adela is proud to announce that Daniel …See details»
adelabio.com - ADELA | Home
Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can …See details»
ADELA | News - adelabio.com
Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can …See details»
ADELA | Publications - adelabio.com
Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can …See details»
Adela’s multi-cancer blood test shows promise in detecting early …
Jun 16, 2023 Canadian newcomer Adela has shown that its test for detecting the faint traces of cancer in the bloodstream could spot 12 different types of the disease, including many in their …See details»
Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO
Dec 15, 2023 Adela, Inc., an innovator in blood testing for minimal residual disease monitoring and early cancer detection through a proprietary genome-wide methylome enrichment …See details»